| Stem Cell Research and Therapy |
1 |
1 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.95 |
| Lymphoma |
0 |
0.98 |
| Follicular Lymphoma |
0 |
0.7 |
| Diffuse Large B-Cell Lymphoma |
0 |
0.69 |
| B-Cell Lymphoma |
0 |
0.65 |
| Biologic Therapy |
0 |
0.6 |
| Mantle Cell Lymphoma |
0 |
0.58 |
| Leukemia |
0 |
0.99 |
| Toxicology |
0 |
0.37 |
| Antineoplastic Drug |
0 |
0.29 |
| Chemotherapy |
0 |
0.28 |
| Combination Chemotherapy |
0 |
0.25 |
| Cancer |
0 |
0.21 |
| Cell Transplantation |
0 |
0.18 |
| Transplantation |
0 |
0.18 |
| Bone Marrow Transplant |
0 |
0.14 |
| Immunomodulator |
0 |
0.14 |
| Monoclonal Antibody |
0 |
0.14 |
| Anaphylaxis |
0 |
0.13 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.13 |
| Child |
0 |
0.11 |
| Intravenous |
0 |
0.11 |
| Washington |
0 |
0.11 |
| Blood |
0 |
0.07 |
| Missouri |
0 |
0.07 |
| Refractory |
0 |
0.07 |